Professor Glenn A. Okun
The Rabid Capitalist: The Big Point is a summary of a detailed note available to paid subscribers.
Private risk capital has been attracted to the 3D printing industry again. Innovation in bioprinting has excited investors. In fact, it is the fifth wave of investment into this technology, a target for capital that has renamed itself repeatedly to attract funds over the last thirty years. Technological innovation risk, the uncertainties surrounding the speed and magnitude of advancement in research and development, may prolong a venture cycle, such as the one that has prevailed in 3D printing.
Complete content is available for a $15 monthly subscription. Click here to subscribe:
The Rabid Capitalist 
Leave a comment